Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-041496

Director acquired 352,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PATEL SAMIR CHANDRAKANT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-18 Grant or award : show line 1 in the form +252,000 252,000 D
2025-03-18 Grant or award : show line 2 in the form +100,800 100,800 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-18 Grant or award : show line 3 in the form Stock Option (right to buy) +105,913 105,913 D
Loading xslF345X05/ownership.xml…